ISSN 2756-3340
African Journal of Infectious Diseases Research | Vol. 12, No. 5, May 2025 | pp. 177–187
DOI: 10.46882/AJIDR/148766
Article Type: Research Article
Title: Prevalence and antifungal resistance profiles of Aspergillus species causing chronic pulmonary aspergillosis in post-tuberculosis patients
Names of Authors: Chidi Nwosu¹*, Annette Lindstrom²
Authors’ Affiliations: ¹Department of Respiratory Medicine, University of Nigeria Teaching Hospital, Enugu, Nigeria. ²Department of Medical Mycology, Karolinska Institutet, Stockholm, Sweden.
Abstract: Chronic pulmonary aspergillosis frequently complicates residual lung cavities following successful pulmonary tuberculosis treatment, mimicking disease relapse. We determined the prevalence, species distribution, and triazole susceptibility of Aspergillus isolates among symptomatic post-tuberculosis patients. Sputum samples and serum specimens from 240 patients were evaluated using fungal culture, Aspergillus-specific IgG serology, and broth microdilution susceptibility testing. Chronic pulmonary aspergillosis was diagnosed in 19.6 percent of participants, with Aspergillus fumigatus and Aspergillus flavus accounting for 83.0 percent of isolates. Itraconazole and voriconazole resistance was detected in 10.6 percent of Aspergillus fumigatus strains. Routine fungal serology and antifungal susceptibility testing are recommended in post-tuberculosis follow-up clinics.
Keywords: Chronic pulmonary aspergillosis, Post-tuberculosis, Aspergillus fumigatus, Triazole resistance, Fungal serology
Citation: Nwosu C, Lindstrom A (2025). Prevalence and antifungal resistance profiles of Aspergillus species causing chronic pulmonary aspergillosis in post-tuberculosis patients. African Journal of Infectious Diseases Research, 12(5): 177–187. DOI: 10.46882/AJIDR/148766
Manuscript Timeline: Received: March 27, 2025; Revised: April 29, 2025; Accepted: May 11, 2025; Published: May 19, 2025
Subscribe to read the full article: https://mail.internationalscholarsjournals.org/subscribe-to-read